Dubai – Agiomix has joined forces with Avivo Group to offer residents of the UAE an at-home COVID-19 testing service.
Dr Atul Aundhekar, CEO of Avivo Group, said, "Agiomix uses the Reverse Transcriptase Polymerase Chain Reaction (rTPCR) test. This test is the gold standard diagnostic tool for COVID-19. Avivo Group has a home car division and is licensed to send health care workers to residences on call to conduct the test. Many people are scared to venture out, including the elderly, those with children and people of determination for whom driving to a test center could be difficult. Agiomix is our ideal strategic partner in the UAE during this period."
Dr Salah Al Janabi, Managing Director at Agiomix, commented, "Agiomix is delighted with this cooperation which enhances the UAE authorities’ goal of testing as many people as possible."
Ongoing testing and isolation of infected individuals will help contain the spread of the virus and significantly reduce the number of infections across the country.
About Agiomix FZ-LLC
Agiomix FZ-LLC is a Dubai based genomics company. They focus on offering sequencing and genotyping services to research and clinical customers. The organisation's goal is to provide services in genomics analysis that are of a high-quality standard, ensuring they are localized and affordable and come with unparalleled levels of counselling and support.
© Press Release 2020
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
